Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Jun 15, 2024; 16(6): 2555-2570
Published online Jun 15, 2024. doi: 10.4251/wjgo.v16.i6.2555
Published online Jun 15, 2024. doi: 10.4251/wjgo.v16.i6.2555
Figure 7 Role of insulin like growth factor binding protein 1 in Epstein-Barr virus-associated gastric cancer and Epstein-Barr virus-negative gastric cancer cell lines.
A: the expression of insulin like growth factor binding protein 1 (IGFBP1) in Epstein-Barr virus-associated gastric cancer (EBVaG) and Epstein-Barr virus-negative gastric cancer (EBVnGC) cell lines; B: Role of IGFBP1 in proliferation in EBVaG and EBVnGC cell lines; C: Role of IGFBP1 in migration in EBVaG and EBVnGC cell lines; D: Role of IGFBP1 in apoptosis in EBVaG and EBVnGC cell lines. aP < 0.05, bP < 0.01, cP < 0.001. IGFBP1: Insulin like growth factor binding protein 1; NC: Normal control; PI: Propidium iodide.
- Citation: Zhang Y, Zhou F, Zhang MY, Feng LN, Guan JL, Dong RN, Huang YJ, Xia SH, Liao JZ, Zhao K. N6-methyladenosine methylation regulates the tumor microenvironment of Epstein-Barr virus-associated gastric cancer. World J Gastrointest Oncol 2024; 16(6): 2555-2570
- URL: https://www.wjgnet.com/1948-5204/full/v16/i6/2555.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i6.2555